The Emerging Role of Minimal Residual Disease in Multiple Myeloma
View IssueHOPA News
HOPA News is the association news materials featuring clinical content, practice management information, pharmacy and association events, and news important to all pharmacists who work in hematology/oncology. The Editorial Board is composed of members who serve on the Publications Committee and act as writers, editors, and peer reviewers.
Past Newsletters
2024
New Horizons for Resectable Non-Small Cell Lung Cancer: Updates in Perioperative Treatment
View Issue2023
Indication Withdrawls of Small Molecule Inhibitors from the Accelerated Approval Program
View IssuePutting All of Our Eggs in Baskets Trials: New Tumor-Agnostic Approvals
View Issue2022
Overcoming Challenges to Provide BiTe and Car T Cell Therapy at a Community Career Center
View IssueClinical Trial Management in the Post-Pandemic Era: Reflections of an Investigational Drug Service on the Past Two Years
View IssueB-Cell Maturation Antigen Targeting CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma
View Issue2021
2020